Back to 
Viking Global Investors LP
Viking Global Investors LP
PACB
Showing 0 of 5 quarters
Position history for Viking Global Investors LP's holdings in Pacific Biosciences of California, Inc.
No. Viking Global Investors exited its PACB (Pacific Biosciences of California) position in Q3 2021. Its Q2 2021 13F listed 1,273,659 shares worth $44.5M. Viking Global Investors first reported PACB in Q3 2020 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.